Akoya Biosciences Inc (AKYA)
3.91
-0.07
(-1.76%)
USD |
NASDAQ |
Apr 17, 16:00
3.94
+0.03
(+0.77%)
After-Hours: 20:00
Akoya Biosciences Cash from Investing (TTM): 3.347M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.347M |
| September 30, 2023 | 26.07M |
| June 30, 2023 | 34.17M |
| March 31, 2023 | -6.745M |
| December 31, 2022 | -14.08M |
| September 30, 2022 | -37.58M |
| June 30, 2022 | -46.72M |
| Date | Value |
|---|---|
| March 31, 2022 | -5.325M |
| December 31, 2021 | -5.094M |
| September 30, 2021 | 5.924M |
| June 30, 2021 | 6.897M |
| March 31, 2021 | 7.256M |
| December 31, 2020 | 6.728M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-46.72M
Minimum
Jun 2022
34.17M
Maximum
Jun 2023
-1.934M
Average
3.347M
Median
Dec 2023
Cash from Investing (TTM) Benchmarks
| Bruker Corp | -326.00M |
| Azenta Inc | 473.42M |
| Harvard Bioscience Inc | -1.799M |
| Bionano Genomics Inc | 24.16M |
| Singular Genomics Systems Inc | 13.81M |